Private equity firm InvAscent plans to list five portfolio companies in the health and pharmaceutical sectors over the next 24–36 months, providing exit opportunities for the investor.
Fleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs with two regulatory-approved manufacturing units. The company sells to customers in over 65 countries across Latin America, Europe, Asia, and MENA.
Homegrown healthcare-focussed private equity firm InvAscent has hit the first close for its latest fund, even as it struck a fresh investment in an active ..